What is the market doing?
What the tape says about RPRX
Royalty Pharma plc is +71% over the past year while the S&P 500 is +23%: 48 points ahead of the market.
+71%
1-year return · S&P 500 +23%
- vs 200-day average
- +32%
vs 200-day average · a clear uptrend
- RSI (14)
- 73
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −0.44%
Below its 52-week high
Details›
- Last close2026-08-26
- $61.80
- 1 monthS&P 500 +3.7%
- +4.7%
- 1 yearS&P 500 +23%
- +71%
- 5 yearsS&P 500 +87%
- +87%
- vs 50-day average$57.16
- +8.1%
- 52-week high
- $62.08
- 52-week low
- $34.37
- Annualised volatility
- 24%
| Year | Return |
|---|---|
| 2026 (year to date) | +61% |
| 2025 | +55% |
| 2024 | −6.4% |
| 2023 | −27% |
| 2022 | +0.99% |
| 2021 | −19% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 4 of 6 | +4.4% |
| Feb | 6 | 3 of 6 | +2.7% |
| Mar | 6 | 3 of 6 | −1.7% |
| Apr | 6 | 4 of 6 | +1.5% |
| May | 6 | 2 of 6 | −0.88% |
| Jun | 6 | 3 of 6 | +0.35% |
| Jul | 7 | 5 of 7 | +0.86% |
| Aug | 7 | 3 of 7 | −0.69% |
| Sep | 6 | 1 of 6 | −3.6% |
| Oct | 6 | 3 of 6 | +0.47% |
| Nov | 6 | 5 of 6 | +5.0% |
| Dec | 6 | 3 of 6 | +0.60% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.